Search research articles
Contact Us
Filters
Showing results (691-700 of 709) with videos related to
Page
of 71
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation
Capucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.
Signal Transduction and Targeted Therapy
|
June 10, 2022
LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)
Xi Shi, Zihao Wang, Wei Ren, et al.
Pharmacological Research
|
March 22, 2023
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
Cong Xu, Ze-Bo Jiang, Le Shao, et al.
Nature Neuroscience
|
July 27, 2010
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
William R Marrs, Jacqueline L Blankman, Eric A Horne, et al.
Cell Reports. Medicine
|
January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Eclinicalmedicine
|
January 3, 2024
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
Yi Fang, Jing-Xin Li, Davone Duangdany, et al.
Nature Communications
|
September 9, 2025
Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome
Jieqing Fan, Danyang Liu, Zhu Ming, et al.
Nature Communications
|
January 12, 2021
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
Chao Zhang, Yifan Wang, Yuanfei Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
JAMA
|
January 11, 2018
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
Sylvia K Plevritis, Diego Munoz, Allison W Kurian, et al.
Page
of 71
Search research articles
Search
Showing results (691-700 of 709) with videos related to
Sort By:
Page
of 71
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation
Capucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.
Signal Transduction and Targeted Therapy
|
June 10, 2022
LDL receptor-related protein 1 (LRP1), a novel target for opening the blood-labyrinth barrier (BLB)
Xi Shi, Zihao Wang, Wei Ren, et al.
Pharmacological Research
|
March 22, 2023
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer
Cong Xu, Ze-Bo Jiang, Le Shao, et al.
Nature Neuroscience
|
July 27, 2010
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
William R Marrs, Jacqueline L Blankman, Eric A Horne, et al.
Cell Reports. Medicine
|
January 19, 2023
Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Han-Min Wang, Chan-Yuan Zhang, Kai-Cheng Peng, et al.
Eclinicalmedicine
|
January 3, 2024
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
Yi Fang, Jing-Xin Li, Davone Duangdany, et al.
Nature Communications
|
September 9, 2025
Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome
Jieqing Fan, Danyang Liu, Zhu Ming, et al.
Nature Communications
|
January 12, 2021
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections
Chao Zhang, Yifan Wang, Yuanfei Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
JAMA
|
January 11, 2018
Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012
Sylvia K Plevritis, Diego Munoz, Allison W Kurian, et al.
Page
of 71